Dharam Verma

Ind Swift

Established in 1995 Ind-Swift has fast evolved towards a business model that is focused on deep-rooted domestic presence and leveraged on high-value mature regulated markets along with considerable growth in emerging markets: Ind-Swift Laboratories Ltd. (Manufacturer of APIs) Ind-Swift Ltd. (Manufacturer of Finished Dosage Forms) Ind-Swift Laboratories Inc. (US Subsidiary) Ind Swift Menthol With manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry. In house capabilities for Development of APIs, Finished Dosage forms, Non-Infringing Process & World Class facilities for Contract Manufacturing are the inherent strengths.